Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments

This webinar examines the most recent developments in the treatment of hormone-sensitive prostate cancer. It follows on from “Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice” held in April. In three talks, we will examine the role of treatment intensification, radioligand therapy and the personalized approach in mHSPC. The webinar will take approximately one hour and includes the possibility to ask questions during the Q&A.

Published Fri, 29 Jul 2022
E Course
Organiser ESU
Duration Approx. 60 minutes

Contact our organiser